Zepbound® (tirzepatide) is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off. Learn more about Zepbound.

Learn more about the Zepbound® savings card (no Gov`t beneficiaries, terms apply), the Zepbound cash option, and LillyDirect™, an online pharmacy solutions option.

In rats, tirzepatide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. It is unknown whether Zepbound causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been determined.

Zepbound® is available in an injectable single-dose pen and a single-dose vial, administered with a needle and a syringe. Learn about dosing, how to inject, and more.

Zepbound delays gastric emptying and thereby has the potential to impact the absorption of concomitantly administered oral medications. Caution should be exercised when oral medications are concomitantly administered with Zepbound.

Eligibility criteria, and terms and conditions for the Zepbound Savings Card Program may change from time to time; the most current version can be found at https://zepbound.lilly.com/coverage-savings.

Learn more about Zepbound's® (tirzepatide) weight reduction (WR) efficacy and safety clinical data around obesity and excess weight.

What is Zepbound? Zepbound is an injectable prescription medicine that may help adults with obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off. Zepbound should be used with a reduced-calorie diet and increased physical activity.

Zepbound ® (ZEP-baund) es una medicina inyectable recetada que podría ayudar a los adultos con: obesidad o algunos adultos con sobrepeso, que también tienen problemas médicos relacionados con este, a perder el exceso de peso corporal sin recuperarlo.

Learn more about Zepbound's® (tirzepatide) efficacy and safety clinical data for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity.